Article info
PDFCorrespondence
Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’
- Correspondence to Dr Jian-Long Guan, Division of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China; jianlong_guan{at}126.com
Citation
Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’
Publication history
- Received December 28, 2020
- Accepted December 30, 2020
- First published January 25, 2021.
Online issue publication
March 10, 2023
Article Versions
- Previous version (25 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.